SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has submitted copies of a newspaper publication to BSE and NSE as a regulatory compliance filing. The publication informs shareholders about a SEBI-mandated special window (per circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated July 2, 2025) for re-lodging physical share transfer requests that were rejected, returned, or left unprocessed before the April 1, 2019 deadline. The 6-month window runs from July 7, 2025 to January 6, 2026. The filing was signed by Company Secretary Thirumalesh Tumma on July 31, 2025, and is purely procedural in nature.
This is a routine compliance filing with no material impact on the stock price or business. It only matters to shareholders whose physical share transfer requests were rejected before April 2019 and who now wish to re-submit them (in dematerialised form).